Serial Number
79440214
Owner
Harness Therapeutics LimitedAttorney
Rebecca LiebowitzFiling Date
Nov 26, 2025
MISBA Trademark
Serial Number: 79440214
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Rebecca Liebowitz Venable LLP
P.O. Box 34385
Washington, DC 20043
United States
Trademark Details
Filing Date
November 26, 2025
Registration Date
Not Registered
Goods & Services
Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, autoimmune conditions and disorders, neurological disorders, neurodegenerative disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes, for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, autoimmune conditions and disorders, neurological disorders, neurodegenerative disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, and polynucleotides for medical and veterinary use; gene editing enzymes for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA, for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, autoimmune conditions and disorders, neurological disorders, neurodegenerative disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents for medical or veterinary use
Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, and biological preparations in the nature of DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
Scientific and technological services and research and design relating thereto, namely scientific research services in the field of genomics; medical and veterinary research services, including the manipulation of biological reagents to be used for medical, veterinary or therapeutic purposes; chemical and biological analysis and research services; medical and scientific research into DNA and RNA; medical and scientific research and product development into regarding the creation of DNA and RNA; medical and scientific research and product development services in the field of the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; medical and scientific research, product development, product testing and research laboratory analysis services in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, and gene mapping; scientific and medical research in the fields of molecular biology, next generation sequencing, high-throughput sequencing, and bioinformatics; medical and scientific research in the fields of DNA and RNA modelling services; gene engineering services; medical and scientific research and product development services regarding the creation of genome libraries or collections of biologicals including chemicals and compounds; medical and scientific research and product development services in regarding creating libraries or collections of normal and mutated genes; scientific services relating to the discovery and the preclinical and clinical development of therapeutic products; medical and scientific research consultancy